Patent · US Active

Biomarker for ovarian cancer CTAP3-related proteins

US9816995B2 · kind B2 · utility

0Cited by

2References

1Claims

0Family size

Assignees

VERMILLION, INC. · US
THE JOHNS HOPKINS UNIVERSITY · US

Inventors

Zhen Zhang · Dayton, US
Daniel W. Chan · Clarksville, US
Eric T. Fung · Austin, US
Zheng Wang · 安丰镇, CN
Fujun Zhang · Hangzhou City, CN

Key dates

Filing date	Mar 18, 2014
Grant date	Nov 14, 2017
Priority date	—
Expiry date	Mar 18, 2034

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/52
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention provides a protein-based biomarker that is useful in qualifying ovarian cancer status in a patient. In particular, the biomarker of this invention is useful to classify a subject sample as ovarian cancer or non-ovarian cancer. The biomarker can be detected by SELDI mass spectrometry.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.